Glenmark Pharma Q3 PAT at Rs 348 crore
NEW DELHI: Glenmark Pharmaceuticals said its consolidated profit after tax stood at Rs 348 crore for the third quarter ended December 31, 2024, aided by strong performance across regions. The drug firm reported a loss of Rs 351 crore in the Oct-Dec quarter of the last fiscal.
Unlock Investment Potential: Enroll in ET's Stock Valuation Workshop - Batch 3. Secure Your Spot Now!
Unlock Investment Potential: Enroll in ET's Stock Valuation Workshop - Batch 3. Secure Your Spot Now!
Popular from Business
- BSNL turns profitable after 17 years, posts Rs 262 crore profit in Q3
- Donald Trump’s reciprocal tariffs: What it means for India
- New Income Tax Bill 2025 explained: 10 key takeaways for taxpayers - top points you should know
- New Income Tax Bill 2025: Six aspects to take note - is it a zero-sum game?
- Will banks be open on March 31, 2025? Here’s what the latest RBI direction says
end of article
Trending Stories
- BSNL turns profitable after 17 years, posts Rs 262 crore profit in Q3
- New Income Tax Bill 2025: Six aspects to take note - is it a zero-sum game?
- Will banks be open on March 31, 2025? Here’s what the latest RBI direction says
- Stock market today: BSE Sensex rises 300 points; Nifty50 near 23,100
- New Income Tax Bill 2025: Read full text of proposed new I-T Act
- Adani Group set to withdraw from $442 million wind power project in Sri Lanka: Report
- New Income Tax Bill 2025 Live Updates: FM Nirmala Sitharaman likely to table New Income Tax Bill in Parliament today
Visual Stories
- 8 smart ways to revise effectively during preparatory leaves
- 7 Ways to Make Your Answers Stand Out and Score Higher Marks
- 8 effective idioms and phrases to stand out in your next interview
- 8 Practical Approaches for College Students to Strengthen their Soft Skills
- 9 smart tricks to finish lengthy exam paper on time
TOP TRENDS
UP NEXT
Start a Conversation
Post comment